- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-8-8-mer
- Ligands
- 8 x CDL: CARDIOLIPIN(Non-covalent)
- 16 x PLX: (9R,11S)-9-({[(1S)-1-HYDROXYHEXADECYL]OXY}METHYL)-2,2-DIMETHYL-5,7,10-TRIOXA-2LAMBDA~5~-AZA-6LAMBDA~5~-PHOSPHAOCTACOSANE-6,6,11-TRIOL(Non-covalent)
PLX.2: 16 residues within 4Å:- Chain A: L.162, V.163, G.166, G.167, M.171, S.202, M.206, Y.209, Y.217, Y.219, A.222
- Chain B: A.203, Y.207, E.216
- Ligands: CDL.1, PLX.15
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.162, A:V.163, A:Y.209, A:Y.217, A:A.222
- Hydrogen bonds: A:Y.217, A:Y.219
PLX.3: 6 residues within 4Å:- Chain A: W.183, W.184
- Chain B: V.194, G.201
- Chain H: F.51
- Ligands: PLX.8
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain H- Hydrophobic interactions: B:V.194, H:F.51
PLX.8: 18 residues within 4Å:- Chain B: R.159, V.163, L.164, G.166, G.167, Y.170, M.171, S.202, A.205, M.206, Y.209, Y.217, V.218, Y.219, Q.226
- Chain C: A.203
- Ligands: PLX.3, CDL.7
13 PLIP interactions:13 interactions with chain B- Hydrophobic interactions: B:R.159, B:V.163, B:L.164, B:A.205, B:Y.209, B:Y.217, B:Y.217, B:Y.219
- Hydrogen bonds: B:Y.170, B:Y.170, B:S.202, B:Y.217
- pi-Cation interactions: B:Y.219
PLX.9: 6 residues within 4Å:- Chain B: W.183, W.184
- Chain C: Y.170, F.197, G.201, S.202
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:W.183
PLX.11: 14 residues within 4Å:- Chain C: V.163, L.164, G.166, G.167, M.171, S.202, M.206, Y.217, Y.219, A.222
- Chain D: A.203, Y.207, E.216
- Ligands: CDL.10
4 PLIP interactions:1 interactions with chain D, 3 interactions with chain C- Hydrophobic interactions: D:Y.207, C:L.164
- Hydrogen bonds: C:Y.217, C:Y.219
PLX.12: 5 residues within 4Å:- Chain C: F.175, W.183, W.184
- Chain D: Y.170
- Ligands: CDL.13
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:F.175, C:W.183, C:W.183
PLX.14: 14 residues within 4Å:- Chain A: E.216
- Chain D: L.162, V.163, L.164, G.166, G.167, M.171, S.202, M.206, Y.209, Y.217, Y.219, Q.226
- Ligands: CDL.13
9 PLIP interactions:9 interactions with chain D- Hydrophobic interactions: D:L.162, D:V.163, D:L.164, D:Y.209, D:Y.217
- Hydrogen bonds: D:Y.170, D:Y.170, D:Y.217, D:Y.219
PLX.15: 5 residues within 4Å:- Chain A: G.201
- Chain D: W.183, W.184
- Ligands: CDL.1, PLX.2
No protein-ligand interaction detected (PLIP)PLX.19: 16 residues within 4Å:- Chain I: L.162, V.163, G.166, G.167, M.171, S.202, M.206, Y.209, Y.217, Y.219, A.222
- Chain J: A.203, Y.207, E.216
- Ligands: CDL.18, PLX.30
7 PLIP interactions:7 interactions with chain I- Hydrophobic interactions: I:L.162, I:V.163, I:Y.209, I:Y.217, I:A.222
- Hydrogen bonds: I:Y.217, I:Y.219
PLX.20: 7 residues within 4Å:- Chain I: W.183, W.184
- Chain J: V.194, G.201
- Chain P: F.51
- Ligands: CDL.22, PLX.23
2 PLIP interactions:1 interactions with chain J, 1 interactions with chain P- Hydrophobic interactions: J:V.194, P:F.51
PLX.23: 18 residues within 4Å:- Chain J: R.159, V.163, L.164, G.166, G.167, Y.170, M.171, S.202, A.205, M.206, Y.209, Y.217, V.218, Y.219, Q.226
- Chain K: A.203
- Ligands: PLX.20, CDL.22
13 PLIP interactions:13 interactions with chain J- Hydrophobic interactions: J:R.159, J:V.163, J:L.164, J:A.205, J:Y.209, J:Y.217, J:Y.217, J:Y.219
- Hydrogen bonds: J:Y.170, J:Y.170, J:S.202, J:Y.217
- pi-Cation interactions: J:Y.219
PLX.24: 6 residues within 4Å:- Chain J: W.183, W.184
- Chain K: Y.170, F.197, G.201, S.202
1 PLIP interactions:1 interactions with chain J- Hydrophobic interactions: J:W.183
PLX.26: 14 residues within 4Å:- Chain K: V.163, L.164, G.166, G.167, M.171, S.202, M.206, Y.217, Y.219, A.222
- Chain L: A.203, Y.207, E.216
- Ligands: CDL.25
4 PLIP interactions:3 interactions with chain K, 1 interactions with chain L- Hydrophobic interactions: K:L.164, L:Y.207
- Hydrogen bonds: K:Y.217, K:Y.219
PLX.27: 5 residues within 4Å:- Chain K: F.175, W.183, W.184
- Chain L: Y.170
- Ligands: CDL.28
3 PLIP interactions:3 interactions with chain K- Hydrophobic interactions: K:F.175, K:W.183, K:W.183
PLX.29: 14 residues within 4Å:- Chain I: E.216
- Chain L: L.162, V.163, L.164, G.166, G.167, M.171, S.202, M.206, Y.209, Y.217, Y.219, Q.226
- Ligands: CDL.28
9 PLIP interactions:9 interactions with chain L- Hydrophobic interactions: L:L.162, L:V.163, L:L.164, L:Y.209, L:Y.217
- Hydrogen bonds: L:Y.170, L:Y.170, L:Y.217, L:Y.219
PLX.30: 5 residues within 4Å:- Chain I: G.201
- Chain L: W.183, W.184
- Ligands: CDL.18, PLX.19
No protein-ligand interaction detected (PLIP)- 6 x CA: CALCIUM ION(Non-covalent)(Non-functional Binders)
CA.4: 4 residues within 4Å:- Chain A: E.192
- Chain B: E.192
- Chain C: E.192
- Chain D: E.192
5 PLIP interactions:1 interactions with chain B, 1 interactions with chain A, 2 interactions with chain D, 1 interactions with chain C- Metal complexes: B:E.192, A:E.192, D:E.192, D:E.192, C:E.192
CA.5: 2 residues within 4Å:- Chain B: D.189
- Chain C: D.189
No protein-ligand interaction detected (PLIP)CA.6: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)CA.16: 4 residues within 4Å:- Chain I: E.192
- Chain J: E.192
- Chain K: E.192
- Chain L: E.192
5 PLIP interactions:1 interactions with chain J, 2 interactions with chain L, 1 interactions with chain K, 1 interactions with chain I- Metal complexes: J:E.192, L:E.192, L:E.192, K:E.192, I:E.192
CA.17: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)CA.21: 2 residues within 4Å:- Chain J: D.189
- Chain K: D.189
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhuo, W. et al., Structure of intact human MCU supercomplex with the auxiliary MICU subunits. Protein Cell (2021)
- Release Date
- 2020-09-09
- Peptides
- Calcium uniporter protein, mitochondrial: ABCDIJKL
Essential MCU regulator, mitochondrial: EFGHMNOP - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
AC
BD
DI
KJ
LK
ML
NE
HF
EG
FH
GM
ON
PO
QP
R
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-8-8-mer
- Ligands
- 8 x CDL: CARDIOLIPIN(Non-covalent)
- 16 x PLX: (9R,11S)-9-({[(1S)-1-HYDROXYHEXADECYL]OXY}METHYL)-2,2-DIMETHYL-5,7,10-TRIOXA-2LAMBDA~5~-AZA-6LAMBDA~5~-PHOSPHAOCTACOSANE-6,6,11-TRIOL(Non-covalent)
- 6 x CA: CALCIUM ION(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhuo, W. et al., Structure of intact human MCU supercomplex with the auxiliary MICU subunits. Protein Cell (2021)
- Release Date
- 2020-09-09
- Peptides
- Calcium uniporter protein, mitochondrial: ABCDIJKL
Essential MCU regulator, mitochondrial: EFGHMNOP - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
AC
BD
DI
KJ
LK
ML
NE
HF
EG
FH
GM
ON
PO
QP
R